linjc16/ctgov huggingface dataset:
Project ALIVE (A Lifestyle Intervention Via Email)

Study Overview
=================
Brief Summary
-----------------
The objective of this study is to test the effectiveness of an email-based diet and physical activity intervention on increasing physical activity and fruit and vegetable consumption and decreasing intake of saturated and trans fats and added sugars.

Official Title
-----------------
Email-Based Diet and Activity Promotion in Worksites

Conditions
-----------------
Inactivity

Intervention / Treatment
-----------------
* Behavioral: ALIVE


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: regional Northern California KP employees Exclusion Criteria: none

Ages Eligible for Study
-----------------
Minimum Age: 21 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention<br>ALIVE - received emails about chosen behavioral intervention path - physical activity, fruits/vegetables or fats/sugars | Behavioral: ALIVE<br>* ALIVE email-based behavioral program based on the participants selected intervention - physical activity, fats/sugars or fruits/vegetabls<br>|
| No Intervention: Control<br>no intervention | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| change in physical activity |  | 4 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| change in fruits and vegetables |  | 4 months | 
| health-related quality of life |  | 4 months | 
| presentism |  | 4 months | 
| stage of change |  | 4 months | 
| self efficacy |  | 4 months |
Vancomycin-Associated Nephrotoxicity

Study Overview
=================
Brief Summary
-----------------
The primary goal of this study is to determine if there is an association between greater exposure to vancomycin and the development of nephrotoxicity. The secondary goal is to estimate the costs to the hospital associated with these nephrotoxic events.

Official Title
-----------------
Occurrence and Economic Impact of Nephrotoxicity Associated With Vancomycin Exposure

Conditions
-----------------
Nephrotoxicity

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 18 years or older at time of hospital admission Had an absolute neutrophil count of ≥ 1000 cells/mm^3 Received > 48 hours of intravenous vancomycin therapy Had one or more vancomycin trough levels reported within the 96 hours after therapy initiation Had a baseline serum creatinine level of < 2.0 mg/dL and baseline creatinine clearance level of ≥ 30 mL/min Exclusion Criteria: Previous diagnosis of cystic fibrosis

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients receiving vancomycin<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Time to nephrotoxicity |  | within 72 hours post completion of vancomycin therapy | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Hospital costs |  | until discharge | 
| Length of stay |  | until discharge | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
vancomycin, nephrotoxicity, length of stay, costs
Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

Study Overview
=================
Brief Summary
-----------------
Nearly all Parkinson's disease (PD) patients eventually develop abnormal and unwanted movements (dyskinesias; LID) caused by the gold standard treatment, Levodopa. The severity of these movements can range from subtle to extremely debilitating and may or may not interfere with normal activities such as putting on a coat or brushing ones teeth. The purpose of this study is to demonstrate the validity and reliability of objectively measuring dyskinesia with a forceplate.

Detailed Description
-----------------
The main outcome measure of this study are measurements taken every half hour during an inpatient study visit. These measurements include standing on a forceplate for 1 minute while performing a mental task such as reciting the alphabet backwards. During this forceplate stance, a rater will visually score your movements. All participants must be eligible for another Parkinson's disease study at Oregon Health and Science University.

Official Title
-----------------
Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

Conditions
-----------------
Parkinson's Disease

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Parkinsons disease Older than 18 Exclusion Criteria: Must be participating in a Parkinsons disease study at Oregon Health & Science University

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Group 1<br>Groups are defined by another study | |
| Group 2<br>Groups are defined by another study | |
| Group 3<br>Groups are defined by another study | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Forceplate Measure |  | Every 1/2 hour | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Visual Rating Scale |  | every 1/2 hour | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
dyskinesia, Parkinsons disease, measurement
Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease

Study Overview
=================
Brief Summary
-----------------
The study has not yet been completed

Official Title
-----------------
Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease

Conditions
-----------------
Crohn Disease

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: The main inclusion criteria were as follows: had diagnosed CD more than 3 months; had EEN in the past 6 months; were at least 18 years old; agreed to participate in this study. Exclusion Criteria: The exclusion criteria were received treatment from mental health professionals due to any mental or cognitive impairment; suffered from other serious diseases, such as heart, brain, lung, liver and kidney dysfunction; severe infection, anemia, cachexia or other serious complications were found.

Ages Eligible for Study
-----------------
Minimum Age: 14 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Adherence | The adherence of patients was evaluated by the ratio of daily actual intake of energy to daily target energy. | December 2020 to May 2021 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Crohn's disease, Exclusive Enteral Nutrition, Adherence
Hold Parameters on Likely Cardiovascular Depressant Medications

Study Overview
=================
Brief Summary
-----------------
This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient. There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent. Research Question: Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?

Official Title
-----------------
Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)

Conditions
-----------------
Asystole, Bradycardia, Hypotension

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Serial evaluation of the first 50 documented events of Code Blue or call to Rapid Response Team involving hypotension, bradycardia or asystole in the adult inpatient population events beginning January 1, 2006.
Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
Cross Sectional Study of Constipation in Advanced Cancer Patients

Study Overview
=================
Brief Summary
-----------------
Constipation is a common problem in palliative cancer patients. However, there were insufficient randomized controlled trial (RCT) data to identify the best laxative or combination of laxatives in these patients. Traditional Chinese medicine (TCM) in holistic approach is popular among cancer patients. More than half had received at least one form of TCM therapy according to the survey carried in 2008. Chinese herbal medicine (CHM) in compound formulation with nourishing and purging effects simultaneously may be more preferred to relieve constipation by local palliative cancer patients. TCM syndrome differentiated by collecting all symptoms and signs through the classic four diagnostic methods is the foundation for making diagnosis and prescription in TCM practice. The present study is the first local study to evaluate the bowel habits and TCM syndrome of advanced cancer patients with constipation. We hope that the results not only can shed light on patient's own reporting or experience of constipation and the effectiveness of current practice, but also can draw up a CHM formulation for advanced cancer patients with constipation.

Official Title
-----------------
Traditional Chinese Medicine Syndrome Distribution of Advanced Cancer Patients With Constipation

Conditions
-----------------
Palliative Care, Constipation, Traditional Chinese Medicine

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: advanced cancer patients on medication for facilitating bowel movement and/or constipation visual analogue scale >=2 Exclusion Criteria: unable to communicate cognitive impaired put on colostomy bag clinically diagnosed gastrointestinal obstruction at end-of-life

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| TCM syndrome distribution | Five TCM syndromes, i.e. Excess Heat, Qi Stagnation, Qi Deficiency, Yang Deficiency and Yin Deficiency, are differentiated by TCM practitioner. | End of recruitment (estimated timeframe: 3 months) | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| bowel habit | Patient's own reporting or experience of constipation Effectiveness of current practice in relief of constipation | End of recruitment (estimated timeframe: 3 months) | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Palliative Care, Advanced Cancer, Constipation, Traditional Chinese Medicine, Syndrome Distribution
Cognitive Motivational Behavior Therapy for Gamblers

Study Overview
=================
Brief Summary
-----------------
This study will evaluate the effectiveness of cognitive motivational behavior therapy (CMBT) in treating pathological gamblers.

Detailed Description
-----------------
Pathological gambling is developing into a serious public health problem. The rise in gambling problems has stimulated treatment studies, but little progress has been made. A particular concern is the high dropout rates from treatment studies; gamblers often seek treatment, but fail to complete it and relapse. This study will test the effectiveness of CMBT in helping to increase retention rates in gambling treatment studies. The first step in this study is designed to enhance gamblers' readiness for change. When participants are committed to change, CMBT will then address specific cognitive biases regarding the notion of randomness, which is thought to lie at the heart of gambling problems. Behavioral components will also be used to enhance gamblers' coping skills. The participants in this study will be randomly assigned to either CMBT or a Gambler's Anonymous control group. Participants will be assessed prior to and after treatment and at 3- and 6-month follow-up visits. Interviews and questionnaires will be used to assess participants.

Official Title
-----------------
Cognitive-Motivational Behavior Therapy for Gamblers

Conditions
-----------------
Gambling

Intervention / Treatment
-----------------
* Behavioral: Cognitive Motivational Behavior Therapy


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: DSM-IV criteria for pathological gambling Eighth grade reading ability Reside in the Albany, NY area Exclusion Criteria: Diagnosis of serious psychopathology, including psychosis, bipolar disorder, or alcohol or other substance dependence

Ages Eligible for Study
-----------------
Minimum Age: 17 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Intervention/Treatment |
| --- |
|Behavioral: Cognitive Motivational Behavior Therapy|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
Survivorship and Outcomes of Robotically Assisted Patellofemoral UKA

Study Overview
=================
Brief Summary
-----------------
The purpose of the study is to determine the survivorship rate of robotically guided isolated patellofemoral implants at 2, 5 and 10 year postoperative.

Detailed Description
-----------------
The purpose of the study is to determine the survivorship rate of robotically guided isolated patellofemoral implants at 2, 5 and 10 year postoperative.

Official Title
-----------------
Survivorship and Outcomes of Robotically Assisted Patellofemoral UKA

Conditions
-----------------
Patellofemoral Knee Arthroplasty

Intervention / Treatment
-----------------
* Device: Robotically guided patellofemoral UKA isolated patellofemoral implants


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Over 21 years of age underwent primary robotically guided UKA and received an isolated patellofemoral implant at least 24 months post operative as of February 2013 Exclusion Criteria: Patient will be excluded from participation in the study if they are cognitively unable to answer study questions.

Ages Eligible for Study
-----------------
Minimum Age: 21 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patellofemoral Knee Arthroplasty<br>Patient who have received a robotically guided isolated patellofemoral implant. | Device: Robotically guided patellofemoral UKA isolated patellofemoral implants<br>* A robot guided isolated patellofemoral unicompartmental knee arthroplasty procedures to replace only the patellofemoral component of the knee.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| 10 year survivorship of robotically guided isolated patellofemoral implants. | 10 year survivorship of robotically guided isolated patellofemoral implants at 2,5, and 10 year follow up. | 10 years after surgery | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| 2 year survivorship of robotically guided isolated patellofemoral implants. | The survivorship rate of robotically guided isolated patellofemoral implants at 2,5, and 10 year. | 2 years after surgery | 
| 5 year survivorship of robotically guided isolated patellofemoral implants. | The survivorship rate of robotically guided isolated patellofemoral implants at 2,5, and 10 years post operative. | 5 years after surgery | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
osteoarthritis, patellofemoral
Survival Rate of All Ceramic Restorations Treated With Air-Water-Blasting Protocol

Study Overview
=================
Brief Summary
-----------------
This study evaluates retrospectively the survival rate of all-ceramic restorations, cemented using AWB technique (test) compared to those cemented with conventional technique (control)

Detailed Description
-----------------
A retrospective study on ceramic restorations, placed in the period 2003-2014, will be performed to assess the survival rate of all-ceramic restorations cemented adhesively. The effectiveness of cementation largely depend on the method used. The Air-Water-blasting performed prior to conventional acid-etch of dental tissues offers an increase in bond strength compared to the conventional etching technique.

Official Title
-----------------
Long -Term Survival Rate of All Ceramic Restorations Cemented With Air-Water-Blasting Treatment Compared to Control Treatment

Conditions
-----------------
Survival, Prosthesis

Intervention / Treatment
-----------------
* Device: dental restorations


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: patients who received at least one ceramic restoration Exclusion Criteria: patients who received feldspathic ceramic restorations
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Device: dental restorations|partial or complete ceramic restorations bonded to dental tissues after WAB and total etching or after total etching|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| survival rate | integrity of the restorations | 2003-2014 |
Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

Study Overview
=================
Brief Summary
-----------------
Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

Official Title
-----------------
Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

Conditions
-----------------
Congestive Heart Failure

Intervention / Treatment
-----------------
* Device: wearable vital signs sensor


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria Patient's aged 18-65 Patient's scheduled to undergo a Trans-thoracic Echocardiogram (TTE) in an outpatient cardiology clinic or admitted to the Cardiac Care Unit with a swan ganz catheter in place for continuous invasive hemodynamic monitoring Exclusion Criteria Patient's with fragile skin or skin conditions that would prevent them from having a sensor placed Patients undergoing exercise or drug induced cardiac stress test Patients with a visible wound at site of sensor placement 3.4. Patients with structural or functional limitations to peripheral blood flow (known upper extremity peripheral arterial disease, use of vasopressors etc.).

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Adults<br>Adults scheduled to receive a TTE (Trans-esophogeal echocardiogram) | Device: wearable vital signs sensor<br>* vital signs monitoring during standard of care procedures; TTE, swan-ganz catheterization<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Percent agreement with pilot sensor and current standard of vital signs monitoring | Percent agreement with pilot sensor and current standard of vital signs monitoring | 2 years |